News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvera Biosciences Release: Genomic Tests Developed For Specific Treatment Decisions In Breast Cancer



9/13/2007 1:42:25 PM

Woburn, MA, - September 10, 2007 - Collaborators of Nuvera Biosciences from The University of Texas M. D. Anderson Cancer Center reported at the 1st American Society of Clinical Oncology Breast Cancer Symposium Sept. 7-8 in San Francisco that independent genomic tests provide specific information about sensitivity to hormonal therapy, and to a current standard chemotherapy, in order to complement prognostic risk, if untreated.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES